A new genomic urine test can help doctors accurately predict bladder cancer as many as 12 years before clinical signs and symptoms emerge and long before a diagnosis can be made with cystoscopy, the most common method of detection, according to a new study*.
Aerin Medical Inc., a company dedicated to providing Ear, Nose and Throat (ENT) physicians with non-invasive solutions for the treatment of chronic nasal conditions, supports the recent American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS) position statement.
Picarro, Inc. and LESNI A/S announced a strategic partnership aimed at delivering industry-leading Ethylene Oxide (EtO or EO) monitoring solutions to medical device and contract sterilization facilities around the world.
Waters Corporation (NYSE:WAT) introduced Alliance iS, the next-generation intelligent HPLC System, designed to reduce compliance risk by adding new levels of proactive error detection, troubleshooting and ease-of-use.
DermaSensor Inc., a health technology company equipping primary care physicians (PCPs) with a non-invasive device for use in evaluation of suspicious skin lesions, presented a pooled analysis from two clinical studies evaluating the performance of the company's device in detecting skin cancer.
Intera Oncology® Inc. has reintroduced Hepatic Artery Infusion (HAI) therapy to the market after its discontinuation in 2018 by the prior manufacturer dismayed patients and physicians. Hepatic Artery Infusion therapy is giving people with colorectal cancer that has spread to the liver and those with bile duct cancer confined to the liver new hope by delivering local chemotherapy directly to tumors while minimizing side effects elsewhere in the body.
Methodist Le Bonheur Healthcare has acquired a groundbreaking radiation therapy treatment system, in use at only ten cancer treatments centers in the U.S. Called Elekta Unity, the technology monitors a patient's movement while simultaneously delivering targeted radiation therapy to cancerous tumors and tumor beds.
Boston Imaging, the United States headquarters of Samsung’s digital radiography and ultrasound business, introduces the HERA W10 Elite1; the premier model of the HERA platform for Obstetrics and Gynecology that provides clinicians with a suite of powerful artificial intelligence (AI) tools and clinical applications to advance the diagnostic experience.
Heart disease is the leading cause of death in the U.S., according to the Centers for Disease Control and Prevention (CDC). In fact, one person dies from heart disease every 34 seconds.
Phillips-Medisize, a Molex company and leader in the design and manufacture of drug delivery, diagnostic and MedTech devices, has expanded its product portfolio with the introduction of a disposable pen injector.